Biomedical subjects
K W Denson
Publications and source records attributed to K W Denson.
Coagulant and anticoagulant action of snake venoms.
Explore the source record for details and available documents.
Two types of haemophilia (A+ and A-): a study of 48 cases.
Explore the source record for details and available documents.
The coagulant activity of platelets.
Explore the source record for details and available documents.
An investigation of three patients with Christmas disease due to an abnormal type of factor IX.
Three patients with Christmas disease whose plasma was shown to have a prolonged one-stage prothrombin time with ox brain thromboplastin have been investigated. These patients have an inhibitor for the reaction between factor X, factor VII, and ox brain extract. The abnormal constituent responsible for this inhibitor appears to be factor IX whuch is functionally inactive but antigenically indistinguishable from normal factor IX. It is proposed that patients might be classified into haemophilia B(+) for patients with this defect (Christmas disease(+)) and haemophilia B(-) (Christmas disease(-)) for patients who have classical Christmas disease.
Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
Explore the source record for details and available documents.
A modified method for the assay of factor IX.
Explore the source record for details and available documents.
A study of the reaction product of factor 8 and factor IX by gel filtration.
Explore the source record for details and available documents.
"Inhibitor like" effects of hematoporphyrin on factor 8 (Antihaemophilic globulin).
Explore the source record for details and available documents.
Standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
Explore the source record for details and available documents.
The preparation for therapeutic use of a concentrate of factor IX containing also factors II, VII and X.
Explore the source record for details and available documents.
The simplified two-stage assay for Factor 8 using a combined reagent.
Explore the source record for details and available documents.
Proposed specification for a reference thromboplastin preparation for the control of anticoagulant therapy using coumarin type drugs.
Explore the source record for details and available documents.
Third report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
Explore the source record for details and available documents.
Antibody nature of the inhibitor to antihaemophilic globulin (Factor 8).
Explore the source record for details and available documents.
Experiments with factor 8 separated from fibrinogen by electrophoresis in free buffer film.
Explore the source record for details and available documents.
Second report on the standardisation of the one-stage prothrombin time for the control of anticoagulant therapy.
Explore the source record for details and available documents.